Study Assessing the Effects of Darunavir/Ritonavir or Lopinavir/Ritonavir on the Pharmacokinetics of Daclatasvir in Healthy Participants

Completed · Phase 1

Conditions studied: Hepatitis C

In brief

The purpose of this study is to determine whether multiple doses of darunavir/ritonavir or lopinavir/ritonavir affect the pharmacokinetics of daclatasvir in healthy participants.

Key facts

Study ID

NCT02159352

Run by

Bristol-Myers Squibb

People needed

49

Starts

2014-06-01

Expected to finish

2014-07-01

Last updated by the study team

2015-11-30

Who can join

Age: 18 and older, up to 49. Sex: any. Healthy volunteers: accepted.

Where it is running

• Healthcare Discoveries, Llc D/B/A Icon Development Solutions — San Antonio, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.